Vista Pharmaceuticals Ltd. - Research Center
524711 VISTAPH Group (Z) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 5.45 | - | 0.11 | 0.29 | 0.41 |
| Operating profit | -2.09 | -0.35 | -0.47 | -0.74 | -0.68 |
| Interest | 0.64 | 0.49 | 0.55 | 0.35 | 0.98 |
| Gross profit | -2.52 | -0.84 | -0.78 | -1.16 | -1.58 |
| EPS (Rs) | -0.67 | -0.23 | 0.40 | -0.63 | -0.30 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.21 | - | 0.24 | -0.08 | 0.08 |
| Stock adjustment | - | - | -0.26 | 0.26 | - |
| Raw material | 5.18 | - | 0.35 | 0.01 | 0.37 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.86 | 0.08 | 0.18 | 0.39 | 0.38 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.50 | 0.27 | 0.31 | 0.36 | 0.34 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.36 | 0.31 | 0.31 | 0.31 | 0.36 |
| Taxation | 0.10 | -0.32 | -2.56 | 0.84 | -0.83 |
| Net profit / loss | -2.97 | -0.83 | 1.48 | -2.31 | -1.10 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 8.84 | 7.36 | 7.36 | 7.36 | 7.36 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -38.32 | - | -431.68 | -258.97 | -167.22 |
| GPM (%) | -44.54 | - | -223.25 | -554.71 | -320.15 |
| NPM (%) | -52.52 | - | 420.28 | -1102.25 | -223.61 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis